论文部分内容阅读
乳腺癌是危害女性健康及生命的最常见恶性肿瘤,发病率占女性恶性肿瘤的首位。复发转移性乳腺癌预后差,化疗是主要的治疗方法,联合化疗的有效率为30%～80%。多西紫杉醇是新一代紫杉类化疗药物,具有高度抗癌活性。希罗达是新一代靶向性化疗药物,副作用小、口服耐受性较好。我院自2003年8月至2007年8月采用希罗达联合
Breast cancer is the most common malignant tumor that endangers the health and life of women. The incidence of breast cancer is the highest among all the female malignant tumors. The prognosis of recurrent metastatic breast cancer is poor. Chemotherapy is the main treatment. The effective rate of combined chemotherapy is 30% -80%. Docetaxel is a new generation of taxane chemotherapy drugs, with a high degree of anti-cancer activity. Xeloda is a new generation of targeted chemotherapeutic drugs with small side effects and good oral tolerance. Our hospital since August 2003 to August 2007 using Xeloda joint